The 2026 Australian Society for Antimicrobials (ASA) Annual Keryn Christiansen Research Grant of up to $25,000 to support original research will be available soon.
The following conditions apply:
- Funding is limited to ASA financial members
- The Principal Investigator (PI) must have been an ASA member for at least twelve months
- Preference will be given to stand-alone projects that align with the Society’s aims
- Preference will be given to early-career researchers
- The successful applicant will present their work at an ASA annual scientific meeting
- ASA will be acknowledged in all resulting publications and presentations
- 12 and 24 months progress reports must be submitted to the ASA committee and an article for the ASA newsletter
The research funds are to be used for the project, as per the budget application only. ASA does not support an institution’s infrastructure or overhead costs.
The application must be performed online via the ASA website ASA Keryn Christiansen Research Grant Application Form and must include:
- A copy of the PI’s CV.
- Head of Department confirmation of the application and the Department has the resources required to undertake the project.
The grant application and CV will be assessed by a panel of at least six independent reviewers using a standardised scoring system. Applicants will be informed of the decision one week before the ASA annual scientific meeting “Antimicrobials 2026”.
Applications will be accepted online up to 30 October 2025.
Click here for the Research Grant Application Form.
For further enquiries please contact the ASA secretary on info@asainc.net.au.
ASA Antimicrobials 2025 Keryn Christiansen Research Grant Recipient
Abdullah Al Masud
University of New South Wales, NSW
“Exploring the factors impacting antibiotic use and adherence amongst multicultural community members in Australia”
ASA Antimicrobials 2024 Research Grant Recipient
Sewunet Belachew
The University of Queensland, QLD
“Investigating Antimicrobial use in Aboriginal and Torres Strait Islander Queenslanders with Cancer Diagnosis: Insights for Effective Antimicrobial Stewardship”
ASA Antimicrobials 2023 Research Grant Recipient
Kelly Cairns
The Alfred Hospital and Monash University, VIC
“Vanguard Randomised Controlled Trial of Daptomycin Therapeutic Drug Monitoring for Vancomycin Resistant Enterococcus faecium Bloodstream Infections”
ASA Antimicrobials 2022 Research Grant Recipient
Dr Iain J. Abbott
ICPMR The Alfred Hospital and Monash University, VIC
“Optimising antimicrobial therapy to treat problematic biofilms using a novel
pharmacodynamic urinary catheter biofilm model”
ASA Antimicrobials 2020 Research Grant Recipient
Dr Caitlin Keighley
ICPMR Westmead Hospital, NSW
Genomics of Antimicrobial resistance in Candida tropicalis
ASA Antimicrobials 2019 Research Grant Recipient
Kelly Wyres
Monash University, VIC
Understanding the Risks of Emergence of Last Line Drug Resistance in Distinct Strains of Klebsiella pneumoniae
ASA Antimicrobials 2018 Research Grant Recipient
Shakeel Mowlaboccus
University of Western Australia, WA
Molecular mechanism of reduced susceptibility to ceftriaxone and penicillin in Neisseria meningitidis
ASA Antimicrobials 2017 Research Grant Recipient
Dr Christopher Blyth
University of Western Australia, WA
Invasive Staphylococcus aureus Infections and Hospitalisations (ISAIAH) in Australian Children: A Two-year Prospective, Multi-Centre Cohort Examining Contemporary Paediatric Clinical and Molecular Epidemiology of S. aureus
ASA Antimicrobials 2016 Research Grant Recipient
Norelle Sherry and Jason Kwong
University of Melbourne
Genomic Investigation of Carbapenem-resistant Enterobacteriacae in Victoria
ASA Antimicrobials 2014 Research Grant Recipient
Justine Gibson
University of Queensland
Promiscuous plasmids in avian pathogenic (APEC) and faecal Escherichia coli (AFEC): How to safeguard Australia
ASA Antimicrobials 2013 Research Grant Recipient
David Paterson
University of Queensland
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections due to Ceftriaone Non-Susceptible Escherichia coli and Klebsiella spp
ASA Antimicrobials 2012 Research Grant Recipient
Sally Partridge
Westmead Hospital
Complete Sequencing of Selected, Informative Multi-Resistance Plasmids from Enterobacteriaceae Clinical isolates